GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » Tax Expense

HYPMY (Hypera) Tax Expense : $-24 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Hypera Tax Expense?

Hypera's tax expense for the months ended in Sep. 2024 was $-14 Mil. Its tax expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-24 Mil.


Hypera Tax Expense Historical Data

The historical data trend for Hypera's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Tax Expense Chart

Hypera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.66 -15.20 4.70 -18.18 -28.91

Hypera Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.09 -2.97 -3.56 -4.02 -13.62

Hypera Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypera  (OTCPK:HYPMY) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Hypera Tax Expense Related Terms

Thank you for viewing the detailed overview of Hypera's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera Business Description

Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera Headlines

From GuruFocus

Q3 2020 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Hypera SA Acquires Takeda's Portfolio Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2024 Hypera SA Earnings Call Transcript

By GuruFocus News 10-09-2024

Q2 2022 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2021 Hypera SA Earnings Call Transcript

By GuruFocus Research 02-13-2024